Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 15/20 | 0.69 |
| ▸ | ESR2 | Q92731 | 9/20 | 0.69 |
| ▸ | AR | P10275 | 3/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2781063 | 1.00 | ESR1 (0.69) | ESR1ESR2ARTDP1TP53 | |
| SCHEMBL13368742 | 0.94 | ESR1 (0.62) | ESR1ESR2ARTDP1TP53 | |
| SCHEMBL22035220 | 0.89 | ESR1 (0.57) | ESR1ESR2ARTDP1TP53 | |
| SCHEMBL673977 | 0.89 | ESR1 (0.70) | ESR1ESR2ARTDP1TP53 | |
| SCHEMBL12387991 | 0.85 | ALDH1A1 (0.52) | ESR1ESR2ARTDP1ALDH1A1 | |
| SCHEMBL2864420 | 0.84 | ESR1 (0.55) | ESR1ESR2ARTDP1TP53 | |
| SCHEMBL1618019 | 0.83 | ALDH1A1 (0.58) | ESR1ESR2TDP1ALDH1A1HPGD | |
| SCHEMBL9973589 | 0.83 | ALDH1A1 (0.58) | ESR1ESR2TDP1ALDH1A1HPGD | |
| SCHEMBL16147382 | 0.82 | ALOX15 (0.53) | ESR1ESR2TDP1ALDH1A1HPGD | |
| SCHEMBL835556 | 0.82 | ESR1 (1.00) | ESR1ESR2ARTDP1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1401851-B8 | TWO-STAGE PROTECTIVE GROUPS FOR THE SYNTHESIS OF BIOPOLYMERS | FEBIT HOLDING GMBH (DE) | 2008-09-10 | — | — | EP | disclosed |
| EP-1401851-B1 | TWO-STAGE PROTECTIVE GROUPS FOR THE SYNTHESIS OF BIOPOLYMERS | FEBIT BIOTECH GMBH (DE) | 2008-07-02 | — | — | EP | disclosed |
| US-7355036-B2 | Two-stage protective groups for the synthesis of biopolymers | FEBIT AG (DE) | 2008-04-08 | — | — | US | disclosed |
| US-20040197851-A1 | Two-stage protective groups for the synthesis of biopolymers | MR. CHRISTOPHER SEAGON, ESQ. (DE) | 2004-10-07 | — | — | US | disclosed |
| EP-1401851-A1 | TWO-STAGE PROTECTIVE GROUPS FOR THE SYNTHESIS OF BIOPOLYMERS | Febit AG (DE) | 2004-03-31 | — | — | EP | disclosed |
| WO-2003004510-A1 | TWO-STAGE PROTECTIVE GROUPS FOR THE SYNTHESIS OF BIOPOLYMERS | FEBIT AG (DE) | 2003-01-16 | — | — | WO | disclosed |
| US-4219219-A | Developers for pressure-sensitive recording and developing sheets containing them | FUJI PHOTO FILM CO., LTD. (JP) | 1980-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040197851-A1 | Two-stage protective groups for the synthesis of biopolymers | CTRB2, OGG1, CPB2 | ESR1 4453/4885ESR2 2975/4885AR 4641/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.